PR-battered pharma industry spending big on lobbying
Novartis hiked its spending in the first quarter of 2019 by an eye-popping 450 percent to $3.2 million, up from $580,000.
Novartis hiked its spending in the first quarter of 2019 by an eye-popping 450 percent to $3.2 million, up from $580,000.